DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announces that the conference call to discuss the
company's third quarter financial results is rescheduled due
to technical difficulties impacting the conference call
provider. The company now plans to host the conference call
and webcast presentation at 10:30 a.m.
ET (2:30 p.m. GMT) on
Thursday, Oct. 29, 2020.
The webcast player and accompanying slides may be accessed on
the Investors section of Alkermes' website at www.alkermes.com. The
conference call may be accessed by dialing +1
844 602 0380 for U.S. callers and +1 862 298
0970 for international callers. The conference ID is
81030951.
A replay of the conference call will be available through
Thursday Nov. 5, 2020, and may be
accessed by visiting Alkermes' website.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical
company developing innovative medicines in the fields of
neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on addiction and
schizophrenia, and a pipeline of product candidates in development
for schizophrenia, bipolar I disorder, neurodegenerative disorders
and cancer. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download
multimedia:http://www.prnewswire.com/news-releases/alkermes-reschedules-third-quarter-2020-financial-results-conference-call-to-1030-am-et-301163084.html
SOURCE Alkermes plc